Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromelanin MRI: A Tool for Non-invasive Investigation of Dopaminergic Abnormalities in Adolescent Substance Use

NCT06369623 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT06369623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromelanin MRI: A Tool for Non-invasive Investigation of Dopaminergic Abnormalities in Adolescent Substance Use
Lead sponsor
Stony Brook University
Phase
Not applicable
Overall status
Recruiting
Start date
April 6, 2024
Completion date
November 30, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent development